Loading market dashboard

Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
TransMedics Group, Inc. · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2029 | $1.22B | $1.20B - $1.24B | -$227.99M | $7.095 | 5 |
| Dec 2028 | $1.02B | $1.01B - $1.02B | -$191.17M | $5.081 | 6 |
| Dec 2027 | $871.85M | $864.21M - $887.06M | -$163.58M | $3.603 | 9 |
| Dec 2026 | $733.05M | $729.19M - $739.45M | -$137.54M | $2.047 | 9 |
| Dec 2025 | $600.69M | $599.88M - $602.17M | -$112.70M | $2.599 | 9 |
| Dec 2024 | $429.58M | $428.46M - $430.58M | -$80.60M | $0.98 | 7 |
| Dec 2023 | $358.76M | $355.19M - $365.01M | -$67.31M | $0.092 | 6 |
| Dec 2022 | $86.22M | $84.30M - $87.97M | -$31.94M | -$1.326 | 1 |
| Dec 2021 | $28.29M | $27.66M - $28.86M | -$29.04M | -$1.575 | 2 |
| Dec 2020 | $23.98M | $23.45M - $24.47M | -$10.01M | -$1.193 | 2 |
| Dec 2019 | $24.19M | $23.65M - $24.68M | -$10.09M | -$1.843 | 1 |